2-Amino-4-fluorobenzoic acid CAS NO.446-32-2
- FOB Price: USD: 228.00-238.00 /Kilogram Get Latest Price
- Min.Order: 100 Kilogram
- Payment Terms: T/T
- Available Specifications:
99%(100-500)Kilogram99%(500-1000)Kilogram
- Product Details
Keywords
- Afatinib intermediate 2-Amino-4-fluorobenzoic acid
- 99% white powder 2-Amino-4-fluorobenzoic acid
- GMP manufacture 2-Amino-4-fluorobenzoic acid
Quick Details
- ProName: 2-Amino-4-fluorobenzoic acid
- CasNo: 446-32-2
- Molecular Formula: C7H6FNO2
- Appearance: white powder
- Application: 446-32-2; use it as the important int...
- DeliveryTime: 30 day
- PackAge: 25kg/drug
- Port: Shanghai
- ProductionCapacity: 2 Metric Ton/Month
- Purity: 99%
- Storage: Protected from light at R.T
- LimitNum: 100 Kilogram
- Moisture Content: <0.2%
- Impurity: <0.1%
- Loss on drying: <2.0%
Superiority
The product is the key intermediate for producing the Afatinib. And we have produced it for several times from 15-200kg per batch in the API's GMP system. The quality of it is high with above 99% purity and each of related impurity is controlled below 0.1%.
For the market, the complete CMC file of it can be provide, for example, COA, ROS, simple procedure and etc. The following four points are main characteristics of it.
1, high purity
2, white powder
3, produce the key intermediate in large scale.
4, can stock the product for market sale.
Details
BioBond (Shanghai) Pharmaceutical Co. Ltd (shorten as “BioBond”) has been Founded by some famous professors from Shanghai Institute of Materia and Medica, CAS to Develop new drug in nervous drug and antitumor areas, Located in Shanghai Zhangjiang Hi-tech Park, Eastern Areas ( named as National Medical Apparatus Park).
BioBond has an excellent team with rich experiences in development of drug including drug synthesis, pharmacology, drug formulation, drug analysis scientists. There are two professors and four Doctors and a lot of masters in BioBond. It has three main business domains:
1, Supply some key intermediates of API for some pharmaceutical company in the API’s GMP system;
2, Serve big pharmaceutical company in China for Pre-clinical research of APIs and overall solutions;
3, Develop new drug including designing and synthesizing new compounds and then testing activity.